Interleukin-31 receptor subunit alpha — Drug Target

All drugs that target Interleukin-31 receptor subunit alpha — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Interleukin-31 Receptor alpha Antagonist [EPC]

Marketed (1)

• Mitchga · Maruho Co., Ltd. · Interleukin-31 Receptor alpha Antagonist [EPC] · Immunology
  Nemolizumab works by binding to the interleukin-31 receptor subunit alpha, blocking the action of interleukin-31 and reducing inflammation and itching.